Tdam USA Inc. lessened its stake in Monsanto Company (NYSE:MON) by 22.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,292 shares of the basic materials company’s stock after selling 1,836 shares during the period. Tdam USA Inc.’s holdings in Monsanto were worth $754,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Pinnacle Financial Partners Inc. bought a new stake in shares of Monsanto during the 2nd quarter valued at about $114,000. Bruderman Asset Management LLC bought a new stake in shares of Monsanto during the 2nd quarter valued at about $116,000. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after purchasing an additional 750 shares in the last quarter. Armbruster Capital Management Inc. boosted its position in shares of Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after purchasing an additional 125 shares in the last quarter. Finally, Enterprise Financial Services Corp boosted its position in shares of Monsanto by 1.2% during the 2nd quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after purchasing an additional 16 shares in the last quarter. Hedge funds and other institutional investors own 74.98% of the company’s stock.

In related news, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the company’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is owned by company insiders.

Monsanto Company (NYSE MON) opened at $118.13 on Friday. Monsanto Company has a 52 week low of $101.51 and a 52 week high of $122.79. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. The firm has a market capitalization of $52,000.00, a P/E ratio of 21.36, a P/E/G ratio of 1.70 and a beta of 1.05.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the prior year, the business earned $0.07 EPS. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. analysts anticipate that Monsanto Company will post 5.74 earnings per share for the current year.

Several equities research analysts recently commented on the company. Barclays PLC restated an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Royal Bank Of Canada restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research report on Wednesday, August 2nd. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto in a research report on Thursday, October 5th. Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research report on Friday, August 11th. Finally, Vetr lowered Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price on the stock. in a research report on Wednesday, August 2nd. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $124.61.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/tdam-usa-inc-has-754000-holdings-in-monsanto-company-mon/1727483.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.